IDEXX Laboratories EBITDA Margin 2010-2025 | IDXX
IDEXX Laboratories EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2025-03-31 | $3.93B | $1.28B | 32.55% |
2024-12-31 | $3.90B | $1.26B | 32.27% |
2024-09-30 | $3.85B | $1.24B | 32.19% |
2024-06-30 | $3.79B | $1.20B | 31.80% |
2024-03-31 | $3.73B | $1.23B | 33.06% |
2023-12-31 | $3.66B | $1.21B | 33.10% |
2023-09-30 | $3.59B | $1.19B | 33.21% |
2023-06-30 | $3.52B | $1.16B | 33.03% |
2023-03-31 | $3.43B | $1.04B | 30.42% |
2022-12-31 | $3.37B | $1.01B | 29.98% |
2022-09-30 | $3.34B | $0.98B | 29.39% |
2022-06-30 | $3.31B | $0.96B | 29.04% |
2022-03-31 | $3.27B | $1.04B | 31.73% |
2021-12-31 | $3.22B | $1.04B | 32.26% |
2021-09-30 | $3.14B | $1.02B | 32.54% |
2021-06-30 | $3.05B | $0.97B | 31.67% |
2021-03-31 | $2.86B | $0.90B | 31.37% |
2020-12-31 | $2.71B | $0.79B | 29.26% |
2020-09-30 | $2.59B | $0.72B | 27.79% |
2020-06-30 | $2.47B | $0.69B | 27.69% |
2020-03-31 | $2.46B | $0.65B | 26.63% |
2019-12-31 | $2.41B | $0.64B | 26.60% |
2019-09-30 | $2.35B | $0.64B | 27.15% |
2019-06-30 | $2.29B | $0.61B | 26.81% |
2019-03-31 | $2.25B | $0.59B | 26.39% |
2018-12-31 | $2.21B | $0.57B | 25.94% |
2018-09-30 | $2.17B | $0.56B | 25.67% |
2018-06-30 | $2.12B | $0.54B | 25.51% |
2018-03-31 | $2.05B | $0.52B | 25.28% |
2017-12-31 | $1.97B | $0.50B | 25.19% |
2017-09-30 | $1.91B | $0.48B | 25.29% |
2017-06-30 | $1.86B | $0.47B | 25.19% |
2017-03-31 | $1.82B | $0.45B | 24.73% |
2016-12-31 | $1.78B | $0.43B | 24.16% |
2016-09-30 | $1.73B | $0.41B | 23.60% |
2016-06-30 | $1.69B | $0.39B | 23.18% |
2016-03-31 | $1.64B | $0.37B | 22.79% |
2015-12-31 | $1.60B | $0.37B | 23.11% |
2015-09-30 | $1.55B | $0.34B | 21.57% |
2015-06-30 | $1.53B | $0.33B | 21.69% |
2015-03-31 | $1.51B | $0.33B | 21.55% |
2014-12-31 | $1.49B | $0.32B | 21.47% |
2014-09-30 | $1.49B | $0.34B | 23.12% |
2014-06-30 | $1.44B | $0.34B | 23.23% |
2014-03-31 | $1.41B | $0.33B | 23.49% |
2013-12-31 | $1.38B | $0.32B | 23.38% |
2013-09-30 | $1.34B | $0.32B | 24.13% |
2013-06-30 | $1.32B | $0.32B | 24.32% |
2013-03-31 | $1.30B | $0.32B | 24.33% |
2012-12-31 | $1.29B | $0.32B | 24.34% |
2012-09-30 | $1.28B | $0.31B | 23.89% |
2012-06-30 | $1.27B | $0.30B | 23.52% |
2012-03-31 | $1.25B | $0.29B | 23.38% |
2011-12-31 | $1.22B | $0.28B | 23.30% |
2011-09-30 | $1.20B | $0.28B | 23.33% |
2011-06-30 | $1.17B | $0.27B | 23.35% |
2011-03-31 | $1.13B | $0.26B | 22.61% |
2010-12-31 | $1.10B | $0.25B | 22.64% |
2010-09-30 | $1.09B | $0.24B | 22.39% |
2010-06-30 | $1.08B | $0.24B | 22.24% |
2010-03-31 | $1.06B | $0.24B | 22.09% |
2009-12-31 | $1.03B | $0.23B | 21.92% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $41.363B | $3.898B |
IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $197.994B | 86.72 |
Thermo Fisher Scientific (TMO) | United States | $151.802B | 18.36 |
Edwards Lifesciences (EW) | United States | $44.969B | 29.49 |
Alcon (ALC) | Switzerland | $42.113B | 28.46 |
DexCom (DXCM) | United States | $34.106B | 52.72 |
STERIS (STE) | Ireland | $24.071B | 26.54 |
Mettler-Toledo (MTD) | United States | $24.056B | 28.61 |
IQVIA Holdings (IQV) | United States | $24.009B | 13.45 |
Waters (WAT) | United States | $21.101B | 29.77 |
SONOVA HOLDING (SONVY) | Switzerland | $18.538B | 0.00 |
Hologic (HOLX) | United States | $14.197B | 15.43 |
Sysmex ADR (SSMXY) | Japan | $10.588B | 30.04 |
Penumbra (PEN) | United States | $10.235B | 80.33 |
Masimo (MASI) | United States | $8.405B | 31.00 |
Globus Medical (GMED) | United States | $8.016B | 19.10 |
Glaukos (GKOS) | United States | $5.426B | 0.00 |
Teleflex (TFX) | United States | $5.351B | 8.83 |
TransMedics (TMDX) | United States | $4.350B | 94.57 |
Integer Holdings (ITGR) | United States | $4.166B | 21.83 |
PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.333B | 13.89 |
Nihon Kohden (NHNKY) | Japan | $2.223B | 25.49 |
Veracyte (VCYT) | United States | $2.093B | 29.36 |
Elekta AB (EKTAY) | Sweden | $2.075B | 18.66 |
Alphatec Holdings (ATEC) | United States | $1.818B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $1.409B | 0.00 |
Artivion (AORT) | United States | $1.271B | 119.04 |
Pulse Biosciences (PLSE) | United States | $1.206B | 0.00 |
OPKO Health (OPK) | United States | $1.031B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $0.987B | 5.25 |
SiBone (SIBN) | United States | $0.788B | 0.00 |
IRadimed (IRMD) | United States | $0.657B | 33.33 |
RxSight (RXST) | United States | $0.654B | 0.00 |
Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.575B | 8.94 |
Delcath Systems (DCTH) | United States | $0.564B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.560B | 13.18 |
AxoGen (AXGN) | United States | $0.499B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
Semler Scientific (SMLR) | United States | $0.461B | 12.26 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.443B | 0.00 |
AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
NeuroPace (NPCE) | United States | $0.409B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.368B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
Neuronetics (STIM) | United States | $0.253B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.229B | 13.86 |
908 Devices (MASS) | United States | $0.214B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
Sight Sciences (SGHT) | United States | $0.187B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.180B | 0.00 |
CVRx (CVRX) | United States | $0.176B | 0.00 |
Inogen (INGN) | United States | $0.176B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
Accuray (ARAY) | United States | $0.164B | 0.00 |
LENSAR (LNSR) | United States | $0.160B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
Microbot Medical (MBOT) | United States | $0.103B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.080B | 48.40 |
InspireMD (NSPR) | Israel | $0.075B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.051B | 20.71 |
Hyperfine (HYPR) | United States | $0.047B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
Spectral AI (MDAI) | United States | $0.043B | 0.00 |
Precision Optics (POCI) | United States | $0.036B | 0.00 |
Envoy Medical (COCH) | United States | $0.034B | 0.00 |
DarioHealth (DRIO) | United States | $0.031B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
NexGel (NXGL) | United States | $0.016B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
Tenon Medical (TNON) | United States | $0.008B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.004B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |